Cost‐Effectiveness of Colchicine Prophylaxis for Gout Flares When Commencing Allopurinol

别嘌呤醇 痛风 秋水仙碱 医学 药理学 内科学
作者
Philip C. Robinson,Nicola Dalbeth,Peter Donovan
出处
期刊:Arthritis Care and Research [Wiley]
卷期号:73 (10): 1537-1543 被引量:10
标识
DOI:10.1002/acr.24357
摘要

Objective Colchicine prophylaxis to prevent gout flares when commencing urate‐lowering therapy is recommended by international rheumatology society guidelines. Whether this is a cost‐effective intervention is currently unknown. Our objective was to perform a cost‐effectiveness analysis using both a US cost input model and an Australian cost input model. Methods This cost‐effectiveness analysis was completed from the point of view of the third‐party payer. We used a 2‐arm decision tree with 1 arm commencing allopurinol with no colchicine prophylaxis and the other with colchicine prophylaxis. Model inputs were drawn from published literature where available. We completed a univariate and probabilistic sensitivity analysis to confirm the robust nature of the modeling. The time frame for the model was 6 months. Results The colchicine prophylaxis arm resulted in a cost of $1,276 and 0.49 quality‐adjusted life‐years (QALYs), while in the placebo arm the cost was $516 and 0.47 QALYs, with an incremental cost‐effectiveness ratio of $34,004 per QALY gained. In Australia, where cost of colchicine was much lower, the colchicine arm dominated the placebo ($208 [Australian] in the colchicine arm versus $415 [Australian] in the placebo). Univariate and probability sensitivity analysis demonstrated that results were robust to changes in input parameters. In the probabilistic sensitivity analysis, the probability of colchicine prophylaxis being the most cost‐effective option was 93% in the US and 100% in the Australian setting. Conclusion Colchicine prophylaxis to prevent gout flares while commencing allopurinol in gout is very cost‐effective.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
frl发布了新的文献求助10
刚刚
刚刚
科研通AI2S应助冥月采纳,获得10
1秒前
所所应助孤独士晋采纳,获得10
1秒前
2秒前
echo发布了新的文献求助20
3秒前
5秒前
Victoria发布了新的文献求助10
5秒前
多情含灵发布了新的文献求助10
6秒前
慕青应助JackeyChen采纳,获得10
7秒前
小马甲应助忧虑的冰姬采纳,获得10
7秒前
7秒前
烟花应助123采纳,获得10
8秒前
cc完成签到,获得积分20
8秒前
8秒前
9秒前
AZUSA完成签到,获得积分20
10秒前
10秒前
在水一方应助猪猪院长采纳,获得10
10秒前
11秒前
朴素烧鹅发布了新的文献求助10
11秒前
superbada完成签到,获得积分10
12秒前
nanween完成签到,获得积分10
12秒前
zhaoyy发布了新的文献求助10
12秒前
12秒前
chang发布了新的文献求助10
14秒前
14秒前
14秒前
hhhi应助虚幻靖易采纳,获得10
15秒前
丘比特应助老武采纳,获得10
15秒前
16秒前
科目三应助frl采纳,获得10
16秒前
cookie完成签到,获得积分10
16秒前
畅快的天空完成签到,获得积分10
18秒前
bbanshan完成签到,获得积分10
18秒前
四时万物兮完成签到,获得积分10
19秒前
Orange应助yshhhhhhhh采纳,获得10
20秒前
隐形曼青应助哈哈哈哈哈采纳,获得10
21秒前
22秒前
Victoria发布了新的文献求助10
23秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3988732
求助须知:如何正确求助?哪些是违规求助? 3531027
关于积分的说明 11252281
捐赠科研通 3269732
什么是DOI,文献DOI怎么找? 1804764
邀请新用户注册赠送积分活动 881869
科研通“疑难数据库(出版商)”最低求助积分说明 809021